Comparison of infusion reactions to infliximab and vedolizumab: A retrospective analysis

被引：0
|
作者：
Chan, Webber [1 ,2 ]
Collins, Glen [1 ]
Lee, Esther [3 ]
Mahmoud, Azeez [3 ]
Leong, Rupert [1 ,3 ]
机构：
[1] Concord Repatriat Gen Hosp, Concord West, Australia
[2] Macquarie Univ Hosp, Macquarie Park, NSW, Australia
[3] Singapore Gen Hosp, Singapore, Singapore
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-0929
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [31] Repeated infliximab injection may shift delayed infusion reactions to acute infusion reactions in patients with psoriasis
    Eto, Ayaka
    Nakahara, Takeshi
    Furue, Masutaka
    JOURNAL OF DERMATOLOGY, 2021, 48 (01): : E41 - E42
  • [32] Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies
    van Schie, Karin A.
    Heer, Pleuni Ooijevaar-De
    Kruithof, Simone
    Plasencia, Chamaida
    Jurado, Teresa
    Salcedo, Dora Pascual
    Brandse, Johannan F.
    d'Haens, Geert R. A. M.
    Wolbink, Gerrit Jan
    Rispens, Theo
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07) : 1285 - 1288
  • [33] Early infliximab antibody testing does not prevent infusion reactions when reinitiating infliximab
    Feuerstein, Joseph D.
    GASTROENTEROLOGY INSIGHTS, 2016, 7 (01)
  • [34] VEDOLIZUMAB DOES NOT INCREASE THE RISK OF ENTERIC INFECTIONS AS COMPARED TO INFLIXIMAB: A RETROSPECTIVE COHORT STUDY
    Meserve, Joseph D.
    Dulai, Parambir
    Park, Sunhee
    Evans, Elisabeth
    Singh, Siddharth
    Sandborn, William J.
    Boland, Brigid S.
    GASTROENTEROLOGY, 2017, 152 (05) : S109 - S110
  • [35] Rapid Infliximab Infusion in Children: A Multicenter Retrospective Cohort Study
    Lev-Tzion, Raffi
    Assa, Amit
    Yerushalmi, Baruch
    Lahad, Avishay
    Friedman, Mira
    Ledder, Oren
    Turner, Dan
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 65 (05): : E101 - E103
  • [36] RETROSPECTIVE STUDY OF DOSE ESCALATION WITH ADALIMUMAB, INFLIXIMAB, AND VEDOLIZUMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Zhang, K. H.
    Singh, H.
    Twardowski, R.
    Lu, C.
    Wan, Y.
    Null, K.
    VALUE IN HEALTH, 2020, 23 : S143 - S143
  • [37] Vedolizumab acute infusion reactions in inflammatory bowel disease patients: results of a multi-centre retrospective observational cohort study
    Venturin, C.
    Nancey, S.
    Roblin, X.
    Peyrin-Biroulet, L.
    Mathieu, N.
    Flourie, B.
    Boschetti, G.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S425 - S425
  • [38] Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis
    Ashleigh Hennessey
    Joanna Lukawska
    Geraldine Cambridge
    David Isenberg
    Maria Leandro
    BMC Rheumatology, 3
  • [39] Predictors of infusion reactions during infliximab treatment in patients with arthritis
    Kapetanovic, Meliha C.
    Larsson, Lotta
    Truedsson, Lennart
    Sturfelt, Gunnar
    Saxne, Tore
    Geborek, Pierre
    ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
  • [40] Predictors of infusion reactions during infliximab treatment in patients with arthritis
    Meliha C Kapetanovic
    Lotta Larsson
    Lennart Truedsson
    Gunnar Sturfelt
    Tore Saxne
    Pierre Geborek
    Arthritis Research & Therapy, 8
12345